Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Abstract Text:

    thomas l hornThomas L Horn,karen e o torresKaren E O Torres,jennifer m naylorJennifer M Naylor,michael j cwikMichael J Cwik,carol j detrisacCarol J Detrisac,izet m kapetanovicIzet M Kapetanovic,ronald a lubetRonald A Lubet,james a crowellJames A Crowell,david l mccormickDavid L McCormick,

    Tamoxifen (TAM) is a nonsteroidal antiestrogen that prevents estrogen receptor-positive breast cancer in rodents and humans. Bexarotene (BEX), a selective agonist for retinoid X receptors, inhibits mammary carcinogenesis in rodents. The present study was conducted to support the preclinical development of TAM (tamoxifen citrate) + BEX for use in breast cancer chemoprevention, and to investigate the influence of these agents on hepatic gene expression. Female CD rats (20 per group) received daily oral (gavage) exposure to TAM (0 or 60 microg/kg/day) and/or BEX (0, 5, 15, or 45 mg/kg/day) for a minimum of 90 days. BEX induced mild, dose-related anemia and dose-related increases in serum alkaline phosphatase, cholesterol, triglycerides, and calcium levels, and increased platelet counts. TAM had no biologically significant effect on any clinical pathology parameter and did not alter the effects of BEX on these endpoints. Microscopic alterations induced by BEX included epidermal hyperplasia, hyperkeratosis (stomach), and cytoplasmic clearing (liver). Microscopic changes in TAM-treated rats were limited to mucous cell hypertrophy in the cervix and vagina. The toxicity of administration of the combination of TAM + BEX can generally be predicted on the basis of the toxicity of each drug as a single agent. BEX induced dose-related alterations in the expression of several genes involved in steroid, drug, and/or fatty acid metabolism; TAM did not alter these effects of BEX. Differential expression of genes involved in drug and lipid metabolism may underlie the observed effects of BEX on cholesterol and triglyceride levels and its effects on liver histology.

    Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Publishing Authors By Initials

    tl hornTL Horn,ke torresKE Torres,jm naylorJM Naylor,mj cwikMJ Cwik,cj detrisacCJ Detrisac,im kapetanovicIM Kapetanovic,ra lubetRA Lubet,ja crowellJA Crowell,dl mccormickDL McCormick,

    For similar biological sciences: biology: genetics: pharmacogenetics: toxicogenetics research abstracts see: biological sciences: biology: genetics: pharmacogenetics: toxicogenetics research

    PUBMED ID PMID:

    MEDLINE DATE:

    Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Toxicological sciences : an official journal of th

    VOLUME: 99

    Page Numbers: 612-27

    Journal Abbreviation: Toxicol. Sci.

    ISSN: 1096-6080

    DAY: 14

    MONTH: 07

    YEAR: 2007

    Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9805461

    Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Keywords Mesh Terms:

    KEYWORDS: Toxicogenetics

    MESH TERMS: toxicity

    Chemical & Substance for Abstract: Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats. Information

    Substance Name: Tamoxifen

    Registry Number: 10540-29-1

    Grant and Affiliation Information for Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats.

    AFFILIATION: Life Sciences Group, IIT Research Institute, Chicago, Illinois 60616, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: N01-CN-43304

    ACRONYM: CN

    MEDLINETA: Toxicol Sci

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Subchronic toxicity and toxicogenomic evaluation of tamoxifen citrate + bexarotene in female rats Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News